EFEXOR

This brand name is authorized in Australia, Brazil, Cyprus, Ecuador, Estonia, Finland, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Netherlands, New Zealand, Singapore, South Africa, Tunisia, Turkey, UK.

Active ingredients

The drug EFEXOR contains one active pharmaceutical ingredient (API):

1	Venlafaxine UNII 7D7RX5A8MO - VENLAFAXINE HYDROCHLORIDE
	Venlafaxine has an antidepressant effect. The mechanism of its action in humans is believed to be associated with its potentiation of neurotransmitter activity in the central nervous system.
	Read more about Venlafaxine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EFEXOR XL Prolonged-release capsule, hard	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AX16	Venlafaxine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8301X, 8302Y, 8868R
BR	Câmara de Regulação do Mercado de Medicamentos	552820050064617, 552820050064717, 552820050064817, 552820050064917, 552820050065017, 552820050065117, 552820050065217, 552820050065317, 552820050065417
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	24.692-09-02, 24.693-09-02, 26.984-04-06
EE	Ravimiamet	1011519, 1044650, 1044661, 1068780, 1068791, 1068803, 1068858, 1068869, 1230297, 1684223, 1684234, 1684245, 1684256, 1684267, 1684278, 1684289, 1684290, 1684302, 1684313, 1684324, 1684335, 1684346, 1684357, 1684368, 1684379, 1684380, 1684391, 1684403, 1684414, 1684425, 1684436, 1684447, 1684458, 1684469, 1684470, 1684481, 1684492, 1684504, 1684515, 1684526, 1684537, 1686236, 1686304
FI	Lääkealan turvallisuus- ja kehittämiskeskus	020277, 438432, 438457
GB	Medicines & Healthcare Products Regulatory Agency	138699, 138702, 142165, 161707, 19272, 19274, 199634, 309912
HK	Department of Health Drug Office	43815, 43816, 54316
IE	Health Products Regulatory Authority	22807, 22820, 22821, 22850, 22896, 22898, 22899, 64302, 64373, 64380, 64381
IL	מִשְׂרַד הַבְּרִיאוּת	4523, 4524
IT	Agenzia del Farmaco	028831055, 028831067, 028831129, 047387016, 048371013, 048371025
LT	Valstybinė vaistų kontrolės tarnyba	1003711, 1004030, 1007763, 1007764, 1008610, 1008611, 1010063, 1010228, 1027449, 1063454, 1063455, 1063456, 1063457, 1063458, 1063459, 1063460, 1063461, 1063462, 1063463, 1063464, 1063465, 1063466, 1063467, 1063468, 1063469, 1063470, 1063471, 1063472, 1063473, 1063474, 1063475, 1063476, 1063477, 1063478, 1063479, 1063480, 1063481, 1063482, 1063483, 1063484, 1063485, 1063486, 1063487, 1063488, 1063489, 1063490, 1063491, 1063492, 1063493, 1063494, 1063495, 1063496, 1063497, 1063498, 1063499, 1063500, 1063501, 1063502, 1063503, 1063504, 1063505, 1063506, 1063507, 1063508, 1063509, 1063510, 1063511, 1063512, 1063513, 1063514, 1063515
MT	Medicines Authority	MA1396/01301
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	266M98
NL	Z-Index G-Standaard, PRK	47511, 47538, 79197
NZ	Medicines and Medical Devices Safety Authority	12119, 5635, 5636
SG	Health Sciences Authority	11435P, 11436P
TN	Direction de la Pharmacie et du Médicament	20403011, 8063171
TR	İlaç ve Tıbbi Cihaz Kurumu	8699532174116, 8699572170017, 8699572170024, 8699572170031, 8699572170048, 8699572170079
ZA	Health Products Regulatory Authority	32/1.2/0318, 32/1.2/0319